Search clinical trials for: pioglitazone HCl

Total 3306 results

Takeda

Terminated

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

Mild Cognitive Impairment Due to Alzheimer's Disease

United States, Australia, United Kingdom, Switzerland
Pfizer

Completed

A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died

Pancreatitis, Acute Necrotizing

United States, Canada
Emory University

Completed

Effect of Thiazolidinediones on Human Bone

Mesenchymal Stem Cells | Bone Density | Osteoblast | Osteocalcin | Adipocytes | Adiponectin

United States
Takeda
Eli Lilly and Company

Completed

Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes (PROactive)

Diabetes Mellitus

Estonia, Latvia, Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Lithuania, Netherlands, Norway, Poland, Slovakia, Sweden, Switzerland, United Kingdom
Takeda

Completed

Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin

Diabetes Mellitus

United Kingdom
Centre Hospitalier Universitaire Vaudois

Unknown

Pioglitazone, Body Composition,Insulin Sensitivity and Protein Metabolism in ESRD

ESRD

Switzerland
Bristol-Myers Squibb

Completed

A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes

Diabetes Mellitus, Non-Insulin-Dependent

United States
Shanghai Jiao Tong University School of Medicine

Completed

Pioglitazone and Losartan Provides Additional Renoprotection

Diabetic Nephropathy | Type 2 Diabetes
Takeda

Completed

Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.

Inflammation | Hypertension

Germany
The University of Texas Health Science Center at...

Recruiting

Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants (PIOHF)

Type 2 Diabetes Mellitus in Obese | Heart Failure With Preserved Ejection Fraction

United States
The University of Hong Kong
Baxter Healthcare Corporation

Completed

Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis Patients (PPAR)

End-stage Renal Disease

Hong Kong
Dong-A ST Co., Ltd.

Completed

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Type2 Diabetes | Non-Alcoholic Fatty Liver Disease

Korea, Republic of
Takeda

Completed

Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy (ADD)

Type II Diabetes Mellitus

Korea, Republic of
University Hospitals Cleveland Medical Center
The Depressive and Bipolar Disorder Alternative Treatment Foundation

Terminated

Pioglitazone for the Treatment of Bipolar Depression

Insulin Resistance | Bipolar Disorder

United States
King Abdulaziz University

Completed

Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes (Pioglitazone)

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus

Saudi Arabia
Takeda

Completed

Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants

Healthy

United States
Takeda
Takeda Pharmaceuticals North America, Inc.

Completed

Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

Diabetes Mellitus
University of Arkansas

Completed

Effect of Thiazolidinedione Treatment Vascular Risk Markers

Vascular Diseases | Diabetes Mellitus, Type 2

United States
Pharmaxis

Completed

Safety and Efficacy of Bronchitol in Bronchiectasis

Bronchiectasis

Australia, New Zealand, United Kingdom
Seoul National University Bundang Hospital
Daewoong Pharmaceutical Co. LTD.

Recruiting

Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis

Type 2 Diabetes

Korea, Republic of
Showa University

Completed

Comparison Between Pioglitazone and SES With type2 DM

Coronary Artery Disease | Type 2 Diabetes Mellitus
Radboud University Medical Center

Completed

Effects of Pioglitazone in Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia

Netherlands
Yonsei University

Completed

Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone

Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)

Korea, Republic of
Takeda

Completed

Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease

Cardiovascular Diseases
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Completed

Clinical Outcomes After Bowel Resection in Patients Receiving Alvimopan Versus Patients Not Receiving Alvimopan in the Premier Perspective Database

Ileus

United States
Stanford University
National Institute of Mental Health (NIMH); National Institutes of Health (NIH)

Completed

Pioglitazone in Patients With Mood Disorders

Insulin Resistance | Major Depressive Disorder

United States
The University of Hong Kong

Completed

Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients

Diabetes | Endstage Renal Disease

Hong Kong
University of Michigan

Completed

Pioglitazone in Hepatitis C

Chronic Hepatitis C

United States
The University of Texas Health Science Center at...

Completed

Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes (PIO-TACE)

Type 2 Diabetes

United States
Tottori University Hospital

Completed

Effects of Pioglitazone in Hypertensive Patients

Hypertension | Insulin Resistance

Japan
Takeda
Eli Lilly and Company

Completed

Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

Diabetes Mellitus

United States
Takeda

Completed

Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.

Coronary Artery Disease | Type 2 Diabetes | Oxidative Stress

Germany
The University of Texas Health Science Center at...
National Institutes of Health (NIH); Takeda Pharmaceuticals North America,...

Completed

Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)

Nonalcoholic Steatohepatitis

United States
University of Virginia
Merck Sharp & Dohme LLC

Completed

Trial of Alvimopan in Major Spine Surgery

Constipation

United States
Amicus Therapeutics

Completed

A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Female Participants With Fabry Disease

Fabry Disease

United States, Australia, France, United Kingdom, Brazil, Canada
Boehringer Ingelheim

Completed

Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers

Healthy
Takeda

Terminated

Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes

United States, Argentina, Mexico, Chile, Peru
Almirall, S.A.
Allergan

Completed

Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris

Acne Vulgaris

United States
University Hospital "Sestre Milosrdnice"
University of Zagreb School of Medicine

Not yet recruiting

The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients

Overweight | Type 2 Diabetes | Disordered Eating Behaviors

Croatia
Takeda

Completed

Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States, Argentina, Mexico, Peru, Chile
Pfizer

Completed

Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)

Healthy

United States
Takeda

Terminated

Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States
University of Colorado, Denver
National Institute on Aging (NIA)

Completed

Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI) (POEM)

Mild Cognitive Impairment

United States
AstraZeneca

Terminated

Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis

Nonalcoholic Steatohapatitis

United States
East Tennessee State University
Takeda Pharmaceuticals North America, Inc.

Completed

The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle

Diabetes Type 2

United States
AstraZeneca

Completed

GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes

Type 2 Diabetes

United States, Canada, France, Mexico
National Institute of Diabetes and Digestive and...

Completed

Exercise and Pioglitazone for HIV-Metabolic Syndromes

HIV Infections | Obesity | Cardiovascular Disease | Type 2 Diabetes | HIV | Lipodystrophy | AIDS

United States
Takeda

Terminated

Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure

Diabetes Mellitus
Incyte Corporation

Terminated

An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

Solid Tumors and Hematologic Malignancy

United States
Emory University
Jaeb Center for Health Research; Insulet Corporation

Completed

Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility

Diabetes Mellitus

United States

Search clinical trials for: pioglitazone HCl

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations